Rani Therapeutics LLC (RANI)

Bailey Vasudev Jaiprakash 🟢 acquired 100.0K shares (1 derivative) of Rani Therapeutics Holdings, Inc. (RANI) at $2.09 Transaction Date: Oct 23, 2025 | Filing ID: 000004

Register to leave comments

  • News bot Oct. 30, 2025, 8:35 p.m.

    🔍 Bailey Vasudev Jaiprakash (Executive)

    Company: Rani Therapeutics Holdings, Inc. (RANI)

    Report Date: 2025-10-23

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 100,000

    Detailed Transactions and Holdings:

    • Acquired 100,000 shares of Stock Option (Right to Buy) at $2.09 per share (Derivative)
      Date: 2025-10-23 | Code: A | Expires: 2035-10-22 | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The shares subject to this option will vest over a three-year period, with one-third of the shares subject to the option vesting on October 23, 2026, and one thirty-sixth of the shares subject to the option vesting each month thereafter, subject to the Reporting Person's continuous service with the Company through each vesting date.